Related Experiment Video
Updated: Apr 25, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Prediction of dynamical drug sensitivity and resistance by module network rewiring-analysis based on transcriptional
Tao Zeng1, Diane Catherine Wang2, Xiangdong Wang3
1Key Laboratory of Systems Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.
Abstract:
Revealing functional reorganization or module rewiring between modules at network levels during drug treatment is important to systematically understand therapies and drug responses. The present article proposed a novel model of module network rewiring to characterize functional reorganization of a complex biological system, and described a new framework named as module network rewiring-analysis (MNR) for systematically studying dynamical drug sensitivity and resistance during drug treatment. MNR was used to investigate functional reorganization or rewiring on the module network, rather than molecular network or individual molecules. Our experiments on expression data of patients with Hepatitis C virus infection receiving Interferon therapy demonstrated that consistent module genes derived by MNR could be directly used to reveal new genotypes relevant to drug sensitivity, unlike the other differential analyses of gene expressions. Our results showed that functional connections and reconnections among consistent modules bridged by biological paths were necessary for achieving effective responses of a drug. The hierarchical structures of the temporal module network can be considered as spatio-temporal biomarkers to monitor the efficacy, efficiency, toxicity, and resistance of the therapy. Our study indicates that MNR is a useful tool to identify module biomarkers and further predict dynamical drug sensitivity and resistance, characterize complex dynamic processes for therapy response, and provide biologically systematic clues for pharmacogenomic applications.
Insights
Module network rewiring-analysis (MNR) reveals how biological modules reorganize during drug treatment. This approach identifies biomarkers for predicting drug sensitivity and resistance in complex diseases.
Area of Science:
- Systems biology
- Pharmacogenomics
- Computational biology
Background:
- Understanding functional reorganization at the network level is crucial for deciphering drug responses and therapeutic mechanisms.
- Existing methods often focus on molecular networks or individual genes, potentially missing higher-level functional changes.
Purpose of the Study:
- To introduce a novel model and framework, module network rewiring-analysis (MNR), for characterizing functional reorganization in complex biological systems.
- To systematically study dynamic drug sensitivity and resistance during therapeutic interventions.
Main Methods:
- Developed and applied the module network rewiring-analysis (MNR) framework to analyze functional reorganization at the module network level.
- Investigated gene expression data from Hepatitis C virus patients undergoing Interferon therapy.
- Focused on module network rewiring rather than individual molecular analysis.
Main Results:
- MNR identified consistent module genes that revealed novel genotypes associated with drug sensitivity, outperforming traditional differential gene expression analyses.
- Functional connections and reconnections among modules, bridged by biological pathways, were found essential for effective drug response.
- Hierarchical structures of the temporal module network served as spatio-temporal biomarkers for monitoring therapy efficacy, toxicity, and resistance.
Conclusions:
- MNR is an effective tool for identifying module biomarkers and predicting dynamic drug sensitivity and resistance.
- The framework aids in characterizing complex dynamic processes underlying therapy response.
- Provides systematic biological insights for pharmacogenomic applications.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
09:58Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Treatment Resistant Cancers
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetics of Drug Metabolism: Overview
Drug toxicity: Idiosyncratic Reactions